{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T02:09:22Z","timestamp":1784167762349,"version":"3.55.0"},"reference-count":58,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Follicle-stimulating hormone (FSH) administration is applied in the management of subjects affected by hypogonadotropic hypogonadism. Whilst this application is widely recognized and established alone or in combination with human chorionic gonadotropin (hCG), a similar strategy is empirically advocated in idiopathic male factor infertility (MFI). In this setting, FSH therapy has been used to increase sperm quantity, quality, and pregnancy rate when FSH plasma concentrations are below 8 IU\/L and when the seminal tract is not obstructed. In the literature, several studies suggested that giving FSH to patients with idiopathic MFI increases sperm count and motility, raising the overall pregnancy rate. However, this efficacy seems to be limited, and about 10\u201318 men should be treated to achieve one pregnancy. Thus, several papers suggest the need to move from a replacement approach to an overstimulating approach in the management of FSH therapy in idiopathic MFI. To this aim, it is imperative to determine some pharmacologic markers of FSH efficacy. Furthermore, it should be useful in clinical practice to distinguish, before starting the treatment, among patients who might respond or not to FSH treatment. Indeed, previous studies suggest that infertile men who have normal levels of gonadotropins in plasma might not respond to FSH treatment and about 50% of patients might be defined as \u201cnon-responders\u201d. For these reasons, identifying predictive markers of FSH action in spermatogenesis and clinical markers of response to FSH treatment is a fascinating area of study that might lead to new developments with the aim of achieving personalization of the treatment of male infertility. From this perspective, seminal parameters (i.e., spermatid count), testicular cytology, genetic assessment, and miRNA or protein markers in the future might be used to create a tailored FSH therapy plan. The personalization of FSH treatment is mandatory to minimize side effects, to avoid lost time with ineffective treatments, and to improve the efficacy, predicting the most efficient dose and the duration of the treatment. This narrative review\u2019s objective is to discuss the role of the different putative factors which have been proposed to predict the response to FSH treatment in idiopathic infertile men.<\/jats:p>","DOI":"10.3390\/life14080969","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T15:26:53Z","timestamp":1722526013000},"page":"969","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["FSH Therapy in Male Factor Infertility: Evidence and Factors Which Might Predict the Response"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3264-0937","authenticated-orcid":false,"given":"Giuseppe","family":"Grande","sequence":"first","affiliation":[{"name":"Unit of Andrology and Reproductive Medicine, Department of Medicine, University of Padua, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3239-2374","authenticated-orcid":false,"given":"Andrea","family":"Graziani","sequence":"additional","affiliation":[{"name":"Unit of Andrology and Reproductive Medicine, Department of Medicine, University of Padua, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9390-6750","authenticated-orcid":false,"given":"Raffaele","family":"Scafa","sequence":"additional","affiliation":[{"name":"Unit of Andrology and Reproductive Medicine, Department of Medicine, University of Padua, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Garolla","sequence":"additional","affiliation":[{"name":"Unit of Andrology and Reproductive Medicine, Department of Medicine, University of Padua, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6607-7105","authenticated-orcid":false,"given":"Daniele","family":"Santi","sequence":"additional","affiliation":[{"name":"Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy"},{"name":"Unit of Endocrinology, Department of Medical Specialties, Azienda Ospedaliero-Universitaria of Modena, 41126 Modena, Italy"},{"name":"Unit of Andrology and Sexual Medicine of the Unit of Endocrinology, Department of Medical Specialties, Azienda Ospedaliero-Universitaria of Modena, 41126 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5817-8141","authenticated-orcid":false,"given":"Alberto","family":"Ferlin","sequence":"additional","affiliation":[{"name":"Unit of Andrology and Reproductive Medicine, Department of Medicine, University of Padua, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,31]]},"reference":[{"key":"ref_1","unstructured":"WHO (2021). Laboratory Manual for the Examination and Processing of Human Semen."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"F1000 Faculty Rev-670","DOI":"10.12688\/f1000research.17076.1","article-title":"Recent Advances in Understanding and Managing Male Infertility","volume":"8","author":"Fainberg","year":"2019","journal-title":"F1000Res"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s40618-022-01741-6","article-title":"Management of Male Factor Infertility: Position Statement from the Italian Society of Andrology and Sexual Medicine (SIAMS): Endorsing Organization: Italian Society of Embryology, Reproduction, and Research (SIERR)","volume":"45","author":"Ferlin","year":"2022","journal-title":"J. Endocrinol. Investig."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/14737159.2019.1633917","article-title":"Contemporary Genetics-Based Diagnostics of Male Infertility","volume":"19","author":"Ferlin","year":"2019","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/humrep\/deae032","article-title":"Guideline for Unexplained Couple Infertility: Misunderstandings on the Approach to the Male Factor","volume":"39","author":"Grande","year":"2024","journal-title":"Hum. Reprod."},{"key":"ref_6","first-page":"739","article-title":"The Follicle-Stimulating Hormone Receptor: Biochemistry, Molecular Biology, Physiology, and Pathophysiology","volume":"18","author":"Simoni","year":"1997","journal-title":"Endocr. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1089\/dna.1987.6.205","article-title":"DNA Sequence and Regional Assignment of the Human Follicle-Stimulating Hormone Beta-Subunit Gene to the Short Arm of Human Chromosome 11","volume":"6","author":"Watkins","year":"1987","journal-title":"DNA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2018.04.001","article-title":"Testosterone and FSH Modulate Sertoli Cell Extracellular Secretion: Proteomic Analysis","volume":"476","author":"Mancuso","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"102310","DOI":"10.1016\/j.bpobgyn.2022.102310","article-title":"Male Infertility and Gonadotropin Treatment: What Can We Learn from Real-World Data?","volume":"86","author":"Esteves","year":"2023","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Santi, D., Cr\u00e9pieux, P., Reiter, E., Spaggiari, G., Brigante, G., Casarini, L., Rochira, V., and Simoni, M. (2020). Follicle-Stimulating Hormone (FSH) Action on Spermatogenesis: A Focus on Physiological and Therapeutic Roles. J. Clin. Med., 9.","DOI":"10.3390\/jcm9041014"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Arato, I., Grande, G., Barrachina, F., Bellucci, C., Lilli, C., Jodar, M., Aglietti, M.C., Mancini, F., Vincenzoni, F., and Pontecorvi, A. (2020). \u201cIn Vitro\u201d Effect of Different Follicle-Stimulating Hormone Preparations on Sertoli Cells: Toward a Personalized Treatment for Male Infertility. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00401"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Casarini, L., Cr\u00e9pieux, P., Reiter, E., Lazzaretti, C., Paradiso, E., Rochira, V., Brigante, G., Santi, D., and Simoni, M. (2020). FSH for the Treatment of Male Infertility. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21072270"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1517\/14712590902932673","article-title":"Recombinant FSH in the Treatment of Oligozoospermia","volume":"9","author":"Foresta","year":"2009","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1210\/endrev\/bnab043","article-title":"New and Consolidated Therapeutic Options for Pubertal Induction in Hypogonadism: In-Depth Review of the Literature","volume":"43","author":"Federici","year":"2022","journal-title":"Endocr. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Behre, H.M. (2019). Clinical Use of FSH in Male Infertility. Front. Endocrinol., 10.","DOI":"10.3389\/fendo.2019.00322"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s40618-018-0843-y","article-title":"The Use of Follicle Stimulating Hormone (FSH) for the Treatment of the Infertile Man: Position Statement from the Italian Society of Andrology and Sexual Medicine (SIAMS)","volume":"41","author":"Barbonetti","year":"2018","journal-title":"J. Endocrinol. Investig."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s12020-009-9302-z","article-title":"Testicular Enlargement in a Patient with a FSH-Secreting Pituitary Adenoma","volume":"37","author":"Dahlqvist","year":"2010","journal-title":"Endocrine"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Spaziani, M., Carlomagno, F., Tenuta, M., Sesti, F., Angelini, F., Bonaventura, I., Ferrari, D., Tarantino, C., Fiore, M., and Petrella, C. (2023). Extra-Gonadal and Non-Canonical Effects of FSH in Males. Pharmaceuticals, 16.","DOI":"10.3390\/ph16060813"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"qfad004","DOI":"10.1093\/sexmed\/qfad004","article-title":"The Availability of Gonadotropin Therapy from FDA-Approved Pharmacies for Men with Hypogonadism and Infertility","volume":"11","author":"Borgert","year":"2023","journal-title":"Sex. Med."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Santi, D., Spaggiari, G., Dalla Valentina, L., Romeo, M., Nuzzo, F., Serlenga, L., Roli, L., De Santis, M.C., Trenti, T., and Granata, A.R.M. (2023). Sperm Concentration Improvement May Be a Parameter Predicting Efficacy of FSH Therapy of Male Idiopathic Infertility. Cells, 12.","DOI":"10.3390\/cells12182236"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4103\/aja.aja_42_19","article-title":"FSH Dosage Effect on Conventional Sperm Parameters: A Meta-Analysis of Randomized Controlled Studies","volume":"22","author":"Cannarella","year":"2020","journal-title":"Asian J. Androl."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1530\/EC-15-0050","article-title":"FSH Treatment of Male Idiopathic Infertility Improves Pregnancy Rate: A Meta-Analysis","volume":"4","author":"Santi","year":"2015","journal-title":"Endocr. Connect."},{"key":"ref_23","first-page":"e15663","article-title":"Past, Present, and Future of Gonadotropin Use in Controlled Ovarian Stimulation During Assisted Reproductive Techniques","volume":"13","author":"Prodromidou","year":"2021","journal-title":"Cureus"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1210\/jcem-65-6-1081","article-title":"Treatment of Severe Oligospermia with Human Chorionic Gonadotropin\/Human Menopausal Gonadotropin: A Placebo-Controlled, Double Blind Trial","volume":"65","author":"Knuth","year":"1987","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Esteves, S.C., Humaidan, P., Ubaldi, F.M., Alviggi, C., Antonio, L., Barratt, C.L.R., Behre, H.M., J\u00f8rgensen, N., Pacey, A.A., and Simoni, M. (2024). APHRODITE Criteria: Addressing Male Patients with Hypogonadism and\/or Infertility Owing to Altered Idiopathic Testicular Function. Reprod. Biomed. Online, 48.","DOI":"10.1016\/j.rbmo.2023.103647"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1093\/humrep\/dew167","article-title":"Treatment with Human, Recombinant FSH Improves Sperm DNA Fragmentation in Idiopathic Infertile Men Depending on the FSH Receptor Polymorphism p.N680S: A Pharmacogenetic Study","volume":"31","author":"Simoni","year":"2016","journal-title":"Hum. Reprod."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Oduwole, O.O., Peltoketo, H., and Huhtaniemi, I.T. (2018). Role of Follicle-Stimulating Hormone in Spermatogenesis. Front. Endocrinol., 9.","DOI":"10.3389\/fendo.2018.00763"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Condorelli, R.A., Cannarella, R., Crafa, A., Barbagallo, F., Mongio\u00ec, L.M., Aversa, A., Greco, E., Calogero, A.E., and La Vignera, S. (2021). Retrospective Monocentric Clinical Study on Male Infertility: Comparison between Two Different Therapeutic Schemes Using Follicle-Stimulating Hormone. J. Clin. Med., 10.","DOI":"10.3390\/jcm10122665"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/cen.12770","article-title":"Treatment of Idiopathic Oligozoospermia with Recombinant Human Follicle-Stimulating Hormone: A Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Study in Chinese Population","volume":"83","author":"Ding","year":"2015","journal-title":"Clin. Endocrinol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Attia, A.M., Al-Inany, H.G., Farquhar, C., and Proctor, M. (2007). Gonadotrophins for Idiopathic Male Factor Subfertility. Cochrane Database Syst. Rev., CD005071.","DOI":"10.1002\/14651858.CD005071.pub3"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Attia, A.M., Abou-Setta, A.M., and Al-Inany, H.G. (2013). Gonadotrophins for Idiopathic Male Factor Subfertility. Cochrane Database Syst. Rev., CD005071.","DOI":"10.1002\/14651858.CD005071.pub4"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/humrep\/13.3.596","article-title":"Recombinant Human Follicle Stimulating Hormone for Treatment of Male Idiopathic Infertility: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial","volume":"13","author":"Kamischke","year":"1998","journal-title":"Hum. Reprod."},{"key":"ref_33","first-page":"747","article-title":"Effects of Highly Purified Follicle-Stimulating Hormone on Sperm DNA Damage in Men with Male Idiopathic Subfertility: A Pilot Study","volume":"34","author":"Palomba","year":"2011","journal-title":"J. Endocrinol. Investig."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2164\/jandrol.111.013326","article-title":"Recombinant Human FSH Reduces Sperm DNA Fragmentation in Men with Idiopathic Oligoasthenoteratozoospermia","volume":"33","author":"Colacurci","year":"2012","journal-title":"J. Androl."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.rbmo.2014.02.014","article-title":"Spermatid Count as a Predictor of Response to FSH Therapy","volume":"29","author":"Garolla","year":"2014","journal-title":"Reprod. Biomed. Online"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10815-013-9951-y","article-title":"Lower Sperm DNA Fragmentation after R-FSH Administration in Functional Hypogonadotropic Hypogonadism","volume":"30","author":"Ruvolo","year":"2013","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s12020-016-1037-z","article-title":"FSH Treatment in Infertile Males Candidate to Assisted Reproduction Improved Sperm DNA Fragmentation and Pregnancy Rate","volume":"56","author":"Garolla","year":"2017","journal-title":"Endocrine"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.rbmo.2018.06.023","article-title":"Sperm DNA Fragmentation Index as a Promising Predictive Tool for Male Infertility Diagnosis and Treatment Management-Meta-Analyses","volume":"37","author":"Santi","year":"2018","journal-title":"Reprod. Biomed. Online"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1745-7262.2005.00043.x","article-title":"Testicular Fine Needle Aspiration as a Diagnostic Tool in Non-Obstructive Azoospermia","volume":"7","author":"Bettella","year":"2005","journal-title":"Asian J. Androl."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0303-7207(99)00228-2","article-title":"FSH in the Treatment of Oligozoospermia","volume":"161","author":"Foresta","year":"2000","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0015-0282(98)00008-9","article-title":"Evidence for a Stimulatory Role of Follicle-Stimulating Hormone on the Spermatogonial Population in Adult Males","volume":"69","author":"Foresta","year":"1998","journal-title":"Fertil. Steril."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0015-0282(01)02966-1","article-title":"Use of Recombinant Human Follicle-Stimulating Hormone in the Treatment of Male Factor Infertility","volume":"77","author":"Foresta","year":"2002","journal-title":"Fertil. Steril."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Schubert, M., P\u00e9rez Lanuza, L., and Gromoll, J. (2019). Pharmacogenetics of FSH Action in the Male. Front. Endocrinol., 10.","DOI":"10.3389\/fendo.2019.00047"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/humrep\/dead277","article-title":"A Cryptozoospermic Infertile Male with Y Chromosome AZFc Microdeletion and Low FSH Levels Due to a Simultaneous Polymorphism in the FSHB Gene: A Case Report","volume":"39","author":"Graziani","year":"2024","journal-title":"Hum. Reprod."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1093\/humrep\/den216","article-title":"FSHB Promoter Polymorphism within Evolutionary Conserved Element Is Associated with Serum FSH Level in Men","volume":"23","author":"Grigorova","year":"2008","journal-title":"Hum. Reprod."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1210\/en.2013-1294","article-title":"A Human FSHB Promoter SNP Associated with Low FSH Levels in Men Impairs LHX3 Binding and Basal FSHB Transcription","volume":"154","author":"Benson","year":"2013","journal-title":"Endocrinology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1210\/clinem\/dgac165","article-title":"A GWAS in Idiopathic\/Unexplained Infertile Men Detects a Genomic Region Determining Follicle-Stimulating Hormone Levels","volume":"107","author":"Schubert","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.fertnstert.2011.09.034","article-title":"Toward a Pharmacogenetic Approach to Male Infertility: Polymorphism of Follicle-Stimulating Hormone Beta-Subunit Promoter","volume":"96","author":"Ferlin","year":"2011","journal-title":"Fertil. Steril."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1210\/jc.2018-02249","article-title":"FSHB -211 G>T Polymorphism as Predictor for TESE Success in Patients with Unexplained Azoospermia","volume":"104","author":"Busch","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e14383","DOI":"10.1111\/and.14383","article-title":"Follicle-Stimulating Hormone Beta Subunit and Receptor Variations in Infertile Men in Central Black Sea Region of Turkey","volume":"54","author":"Hekim","year":"2022","journal-title":"Andrologia"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/andr.12949","article-title":"FSHB and FSHR Gene Variants Exert Mild Modulatory Effect on Reproductive Hormone Levels and Testis Size but Not on Semen Quality: A Study of 2020 Men from the General Danish Population","volume":"9","author":"Bang","year":"2021","journal-title":"Andrology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.2047-2927.2012.00028.x","article-title":"Study in 1790 Baltic Men: FSHR Asn680Ser Polymorphism Affects Total Testes Volume","volume":"1","author":"Grigorova","year":"2013","journal-title":"Andrology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1365-2605.2010.01086.x","article-title":"The Response to FSH Treatment in Oligozoospermic Men Depends on FSH Receptor Gene Polymorphisms","volume":"34","author":"Selice","year":"2011","journal-title":"Int. J. Androl."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/humupd\/dmy019","article-title":"Clinical Relevance of Genetic Variants of Gonadotrophins and Their Receptors in Controlled Ovarian Stimulation: A Systematic Review and Meta-Analysis","volume":"24","author":"Alviggi","year":"2018","journal-title":"Hum. Reprod. Update"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Duarte, T.T., and Spencer, C.T. (2016). Personalized Proteomics: The Future of Precision Medicine. Proteomes, 4.","DOI":"10.3390\/proteomes4040029"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1210\/en.2010-1341","article-title":"Hormonal Regulation of Sertoli Cell Micro-RNAs at Spermiation","volume":"152","author":"Nicholls","year":"2011","journal-title":"Endocrinology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1210\/me.2011-1267","article-title":"mRNA-Selective Translation Induced by FSH in Primary Sertoli Cells","volume":"26","author":"Musnier","year":"2012","journal-title":"Mol. Endocrinol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1038\/sj.onc.1204632","article-title":"The ERK-Dependent Signalling Is Stage-Specifically Modulated by FSH, during Primary Sertoli Cell Maturation","volume":"20","author":"Marion","year":"2001","journal-title":"Oncogene"}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/14\/8\/969\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:27:24Z","timestamp":1760110044000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/14\/8\/969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,31]]},"references-count":58,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["life14080969"],"URL":"https:\/\/doi.org\/10.3390\/life14080969","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,31]]}}}